Johnson & Johnson buys oncology drug developer for $2 billion
Johnson & Johnson announced on the acquisition of Ambrx Biopharma, which develops drugs for the treatment of cancer. J&J will...
Johnson & Johnson announced on the acquisition of Ambrx Biopharma, which develops drugs for the treatment of cancer. J&J will...